HROW
- Harrow Health, Inc.
()
Overview
Company Summary
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a specialty pharmaceutical company based in San Diego, California. The company focuses on developing and commercializing innovative medications and drug formulations primarily in the ophthalmology, urology, and other specialty areas.
Harrow Health operates through two main segments: the Pharmaceutical segment and the Pharmacy compounding segment.
In the Pharmaceutical segment, Harrow Health develops and manufactures high-quality, affordable generic and branded medications. The company emphasizes the development of novel formulations to address unmet needs within the market. They have a particular focus on ophthalmology, providing alternative formulations for eye-related conditions such as dry eye disease, blepharitis, and glaucoma. Other specialty areas include urology, dermatology, and hormone replacement therapy.
The Pharmacy compounding segment includes Harrow Health's subsidiary, ImprimisRx, which operates as a compounding pharmacy. Compounding is the process of customizing medications to the specific needs of patients, often combining multiple active pharmaceutical ingredients into a single dosage form. ImprimisRx provides customized medications to healthcare providers, offering alternatives to commercially available drugs that may be back-ordered, expensive, or not meet the individual patient's requirements.
Harrow Health's business model is driven by a commitment to cost-effective pricing and accessibility, aiming to provide affordable options for patients and healthcare providers. They leverage their manufacturing capabilities, regulatory expertise, and proprietary drug delivery technologies to develop and deliver innovative alternatives to traditional medications.
Overall, Harrow Health's primary focus is on research, development, manufacturing, and commercialization of specialty medications in ophthalmology, urology, and other specialty areas. Through their Pharmaceutical and Pharmacy compounding segments, they strive to address market needs, bring affordable alternatives to patients, and improve overall healthcare outcomes.